Sumitomo Mitsui DS Asset Management’s 10x Genomics TXG Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,026	Closed	-$306K	–	783
2022 Q1	$306K	Hold	4,026	–	–	0.01%	720
2021 Q4	$599K	Hold	4,026	–	–	0.01%	645
2021 Q3	$586K	Sell	4,026 -25	-0.6%	-$4.29K	0.01%	630
2021 Q2	$793K	Buy	4,051 +587	+17%	+$106K	0.02%	568
2021 Q1	$626K	Buy	3,464 +33	+1%	+$5.7K	0.02%	595
2020 Q4	$485K	Buy	+3,431	New	+$498K	0.01%	618

Other funds holding TXG

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

SIM

SRS Investment Management New York $10.8B AUM 34.05% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's TXG Position: Q2 2022 in Review

Sumitomo Mitsui DS Asset Management sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 4,026 shares — an estimated $306K sold.

Sumitomo Mitsui DS Asset Management first reported a position in TXG in Q4 2020 and held it in 6 quarters. The position peaked at $793K in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

Sumitomo Mitsui DS Asset Management reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
Sumitomo Mitsui DS Asset Management sold 4,026 10x Genomics shares in Q2 2022, an estimated $306K.
Sumitomo Mitsui DS Asset Management first reported a position in 10x Genomics in Q4 2020 and held it in 6 quarters.
Sumitomo Mitsui DS Asset Management's 10x Genomics position peaked at $793K in Q2 2021.
254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2022, filed 13 Jul 2022.